2023
DOI: 10.3390/biom13091321
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Aripiprazole and Trazodone Polypharmacy Effects on Systemic and Brain Cholesterol Biosynthesis

Zeljka Korade,
Allison Anderson,
Marta Balog
et al.

Abstract: The concurrent use of several medications is a common practice in the treatment of complex psychiatric conditions. One such commonly used combination is aripiprazole (ARI), an antipsychotic, and trazodone (TRZ), an antidepressant. In addition to their effects on dopamine and serotonin systems, both of these compounds are inhibitors of the 7-dehydrocholesterol reductase (DHCR7) enzyme. To evaluate the systemic and nervous system distribution of ARI and TRZ and their effects on cholesterol biosynthesis, adult mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“… Antipsychotics and antidepressants: Many antidepressants have been shown to colocalise with 5-HT 3 receptors in lipid rafts [ 217 ]. Trazodone, an antidepressant, and aripiprazole, an antipsychotic, have been shown to alter cholesterol metabolism and, therefore, likely affect lipid raft composition and stability [ 218 , 219 ]. …”
Section: Role Of Lipid Rafts In Brain Developmentmentioning
confidence: 99%
“… Antipsychotics and antidepressants: Many antidepressants have been shown to colocalise with 5-HT 3 receptors in lipid rafts [ 217 ]. Trazodone, an antidepressant, and aripiprazole, an antipsychotic, have been shown to alter cholesterol metabolism and, therefore, likely affect lipid raft composition and stability [ 218 , 219 ]. …”
Section: Role Of Lipid Rafts In Brain Developmentmentioning
confidence: 99%